Volume 123, Issue 1 , Pages 59-66.e4, January 2009
IL-17 in atopic eczema: Linking allergen-specific adaptive and microbial-triggered innate immune response
Background
Patients with atopic eczema (AE) regularly experience colonization with Staphylococcus aureus that is directly correlated with the severity of eczema. Recent studies show that an impaired IL-17 immune response results in diseases associated with chronic skin infections.
Objective
We sought to elucidate the effect of IL-17 on antimicrobial immune responses in AE skin.
Methods
T cells infiltrating atopy patch test (APT) reactions were characterized for IL-17 secretion to varying stimuli. IL-17–dependent induction of the antimicrobial peptide human β-defensin 2 (HBD-2) in keratinocytes was investigated.
Results
Approximately 10% of APT-infiltrating T cells secreted IL-17 after phorbol 12-myristate 13-acetate (PMA)/ionomycin stimulation. Among these, 33% belonged to the newly characterized subtype TH2/IL-17. Despite the capacity to secrete IL-17, specific T-cell clones released only low amounts of IL-17 on cognate allergen stimulation, whereas IL-4, IFN-γ, or both were efficiently induced. IL-17 secretion was not enhanced by IL-23, IL-1β, or IL-6 but was enhanced by the S aureus–derived superantigen staphylococcal enterotoxin B. Both healthy and AE keratinocytes upregulated HBD-2 in response to IL-17, but coexpressed IL-4/IL-13 partially inhibited this effect. In vivo, additional application of staphylococcal enterotoxin B induced IL-17 in APT reactions, whereas IL-4, IFN-γ, and IL-10 were marginally regulated. Induced IL-17 upregulated HBD-2 in human keratinocytes in vivo.
Conclusion
IL-17–capable T cells, in particular TH2/IL-17 cells, infiltrate acute AE reactions. Although IL-17 secretion by specific T cells is tightly regulated, it can be triggered by bacteria-derived superantigens. The ineffective IL-17–dependent upregulation of HBD-2 in patients with AE is due to a partial inhibition by the type 2 microenvironment, which could partially explain why patients with AE do not clear S aureus.
Key words: Atopic eczema/dermatitis, TH17, IL-17, superantigen, defensin
Abbreviations used: AE, Atopic eczema, APC, Antigen-presenting cell, APT, Atopy patch test, DC, Dendritic cell, HBD-2, Human β-defensin 2, FITC, Fluorescein isothiocyanate, PE, Phycoerythrin, PMA, Phorbol 12-myristate 13-acetate, SEB, Staphylococcal enterotoxin B, TCR, T-cell receptor
K. Eyerich was supported by a grant of the “Bayerische Forschungsstiftung” (BFS). This work was supported by a grant of the European Community (UE-LSHB-CT-2005-018681) and by the Italian minister of health.
Disclosure of potential conflict of interest: The authors have declared that they have no conflict of interest.
PII: S0091-6749(08)01880-0
doi:10.1016/j.jaci.2008.10.031
© 2009 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
Volume 123, Issue 1 , Pages 59-66.e4, January 2009
